Our Services
Process Development
We optimize upstream and downstream processes for biologics, gene therapies, and large molecules to ensure scalability and reproducibility. Our solutions support seamless transition from preclinical to clinical manufacturing.
Analytical Assay
tBrexa designs, develops, and validates robust analytical methods to support product characterization, release, and stability testing. Our in-house capabilities include bioassays, immunoassays, and molecular analysis.
Formulation Development
We create stable and effective formulations for complex biologics and gene therapies. Our approach focuses on enhancing product shelf life, bioavailability, and patient safety.
Cell Line Development
Using high-yield expression systems, we generate and characterize clonal cell lines optimized for productivity and regulatory compliance. Our services include transfection, clone screening, and stability studies.
Fill and Finish
Our aseptic fill and finish services include formulation, sterile filling, and final packaging of drug products. We offer scalable solutions for preclinical and early-phase clinical programs.
Quality Control (QC) & Release Testing
We perform in-house QC testing including ELISA, HPLC, endotoxin, and sterility assays. Our release and stability testing ensures your product meets regulatory and clinical standards.
Why tBrexa Bio?
At tBrexa Bio, we’re not just a CDMO, we’re your strategic development partner. Our team brings decades of biologics expertise, flexible capacity, and a commitment to delivering on time, every time. Whether you’re scaling up a novel therapy or advancing a complex molecule, we offer hands-on collaboration and quality without compromise.
Our No Obligation Process
Initial
Discovery Call, Feasibility & Proposal
How We Work
Every project starts with understanding your science and ends with a high-quality deliverable. Our streamlined process ensures clarity, speed, and accountability from day one.